Clinical trials

5

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

REVascularization In Large VEssel Occlusion for Acute Ischemic Stroke

The objective of this study is to evaluate the safety and effectiveness of the SOFIA Flow 88 Aspiration Catheter for treatment of acute ischemic stroke.

Participants needed: 200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Microvention-Terumo, Inc.Updated: May 26, 2026
Eligibility criteria

Age ≥18 years on the date of consent [+7]

Any intracranial hemorrhage at baseline [+7]

Status: Not yet recruiting

PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE Trial

This is a prospective, randomized, controlled, open-label, blinded endpoint (PROBE) clinical investigation in which patients with non-emergent chronic subdural hematoma (cSDH) requiring treatment will be randomized (1:1) to either initial surgical evacuation (Control Arm) or initial MMAE with PHIL™ (investigational arm).

Participants needed: 475
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Microvention-Terumo, Inc.Updated: May 8, 2026
Eligibility criteria

Age 22 years or older [+9]

Prior ipsilateral craniotomy or burr hole evacuation of cSDH [+13]

Status: Recruiting

Microvention AnEurysm & STroke Real-life Data cOllection

The MAESTRO registry is a post-market, single-arm, non-interventional, multicenter registry

Participants needed: 1,000
Trial details
Biological sex: AllType: ObservationalSponsor: Microvention-Terumo, Inc.Updated: Feb 9, 2026Locations: 1Duration: 18 Months
Eligibility criteria

Patient, or another authorized person as per country-specific regulations, is in... [+2]

Patient is or is expected to be inaccessible for follow-up. [+2]

Status: Not yet recruiting

FRED Retrospective Study of Intracranial Aneurysms Treatment

To evaluate the long-term safety and efficacy of Flow Re-Direction Endoluminal Device System (FRED) in the treatment of intracranial aneurysms in the post-market environment

Participants needed: 2,000
Trial details
Age: 18-90Biological sex: AllType: ObservationalSponsor: Microvention-Terumo, Inc.Updated: May 21, 2025
Eligibility criteria

People in China mainland who have been treated with FRED. The patients for whom...

Patients who met the inclusion criteria at all time points were required to be i...

Status: Recruiting

European, Multi-center, Exploratory Trial to Assess WEB Versus Other Endovascular Treatment in Ruptured Aneurysms.

Comparison of efficacy and safety between WEB and other endovascular techniques

Participants needed: 80
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Microvention-Terumo, Inc.Updated: Dec 18, 2024Locations: 1
Eligibility criteria

Patient is above 18 years of age at the time of consent [+5]

Aneurysm to be treated is unsuitable for endovascular treatment with commerciall... [+4]